The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Children
Effectiveness and Safety of Inactivated EV71 Vaccine (Human Diploid Cell) in 6-71 Months Children: an Open-label Controlled Phase Ⅳ Clinical Study
Sponsor: Hubei Provincial Center for Disease Control and Prevention
This PHASE4 trial investigates Hand, Foot and Mouth Disease (HFMD) and is currently completed. Hubei Provincial Center for Disease Control and Prevention leads this study, which shows 11 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Nov 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Oct 2023 — Nov 2023 [monthly]
Completed PHASE4
-
Dec 2022 — Oct 2023 [monthly]
Completed PHASE4
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE4
-
May 2019 — Jan 2021 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Apr 2019 — May 2019 [monthly]
Active Not Recruiting PHASE4
-
Jun 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE4
-
May 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE4
First recorded
Sep 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hubei Provincial Center for Disease Control and Prevention
- Institute of Medical Biology, Chinese Academy of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .